Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07386912 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

Study acronym: OXIGENE
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Research Center Borstel
7 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
Asthma
956 trials monitored
See 34 trials at risk
The OXIGENE study is a research project that aims to better understand how the immune system behaves in people with lung diseases such as asthma, COPD, pneumonia, tuberculosis, and viral lung infections. By analyzing a single blood sample, the study examines how certain immune cells react during inflammation and infection, and whether lasting changes in these cells influence how strongly the body responds to disease. Although participants do not receive direct medical benefit, the results may help improve future diagnosis and treatment of lung diseases by providing deeper insight into immune responses.
Trial Details
NCT Number NCT07386912
Lead Sponsor Research Center Borstel
Conditions
(from sponsor)		 Asthma, COPD, Bacterial Pneumonia, Viral Pneumonia, Tuberculosis
Related terms Asthma, Pneumonia, Bacterial, Pneumonia, Viral, Pulmonary Disease, Chronic Obstructive, Tuberculosis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov